US equities |
NVDA $237.81 ▲+1.65% SPCX $167.91 ▲+5.63% MU $1,064.30 ▼-0.99% TSLA $379.09 ▲+2.29% MSFT $524.95 ▲+1.43% SNDK $1,712.74 ▼-0.42% INTC $117.05 ▼-1.91% META $742.08 ▲+1.92%
FinancialContent

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

18.47 -0.10 (-0.54%)
Delayed Quote Updated: 2:10 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Legend Biotech Corporation - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Expert Outlook: Legend Biotech Through The Eyes Of 6 Analysts ↗
 
Via Benzinga
News headline image
Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings
Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to... 
Via MarketMinute
Topics Economy Intellectual Property Stocks
News headline image
How Do Investors Really Feel About Legend Biotech? ↗
 
Via Benzinga
Legend Biotech Considering Second Listing Outside US: Report ↗
Via Stocktwits
News headline image
How Do Investors Really Feel About Legend Biotech? ↗
 
Via Benzinga
News headline image
Earnings Outlook For Legend Biotech ↗
 
Via Benzinga
News headline image
Looking Into Legend Biotech's Recent Short Interest ↗
 
Via Benzinga
News headline image
Is Legend Biotech Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
The Analyst Verdict: Legend Biotech In The Eyes Of 5 Experts ↗
 
Via Benzinga
News headline image
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings.... 
Via MarketMinute
Topics Economy Stocks
News headline image
Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q2 2025 Earnings with Revenue Beat and EPS Miss Amid Strong CARVYKTI Sales ↗
Legend Biotech's Q2 2025 earnings show revenue beat at $255.1M, driven by strong CARVYKTI sales, but EPS missed at -$0.34. Stock rose 1.4% pre-market. 
Via Chartmill
News headline image
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
A Glimpse Into The Expert Outlook On Legend Biotech Through 6 Analysts ↗
 
Via Benzinga
News headline image
What Does the Market Think About Legend Biotech? ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2025 ↗
 
Via Benzinga
News headline image
The FDA Shake-Up Continues, And Could Impact Genetic Medicines ↗
Nicole Verdun and Rachael Anatol were placed on administration leave without explanation. 
Via Investor's Business Daily
Topics Government
News headline image
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
News headline image
Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
News headline image
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst ↗
Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based manufacturing shields it from tariffs and global regulatory risks. 
Via Benzinga
Topics World Trade
News headline image
5 Analysts Have This To Say About Legend Biotech ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >